Trend in approval of targeted biologics in the last two decades
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
Hlavní autor: | Siddika, Khadiza |
---|---|
Další autoři: | Ahmed, Syeda Maliha |
Médium: | Diplomová práce |
Jazyk: | English |
Vydáno: |
Brac University
2024
|
Témata: | |
On-line přístup: | http://hdl.handle.net/10361/24296 |
Podobné jednotky
-
Targeted therapeutic options in the treatment of Breast Cancer
Autor: Alam, Kazi Tasnuva
Vydáno: (2022) -
Study on anticancer drugs approved by the FDA from 2014 to 2023
Autor: Rattry, Faria Rahman
Vydáno: (2024) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
Autor: Tania, Umme
Vydáno: (2023) -
RIPK pathway, as a potential target, for cancer treatment - a review
Autor: Jahan, Nusrat
Vydáno: (2024) -
Molecular biology : genes to proteins /
Autor: Tropp, Burton E.
Vydáno: (2008)